Jungwon Cho

Efficacy and safety findings from DREAM: a phase III study of DHP107 (oral paclitaxel) versus i.v. paclitaxel in patients with advanced gastric cancer after failure of first-line chemotherapy

Yoon‐Koo Kang, Min‐Hee Ryu, Se Hoon Park et al. · Annals of Oncology · 2018 · 54 citations · Full text

Topography and location of the depressor anguli oris muscle with a reference to the mental foramen

Mi Sun Hur, Kyung‐Seok Hu, Jungwon Cho et al. · Surgical and Radiologic Anatomy · 2008 · 44 citations · Full text

Neuroanatomy, Topographical Anatomy, Neurology +6

1300: Efficacy and safety of BI 1482694 (HM61713), an EGFR mutant-specific inhibitor, in T790M-positive NSCLC at the recommended phase II dose

K. Park, J.-S. Lee, J. Y. Han et al. · Journal of Thoracic Oncology · 2016 · 38 citations · Full text

Preclinical Therapeutics, Oncology, Medicine +9

Randomized phase III study of S-1 alone versus S-1 plus docetaxel (DOC) in the treatment for advanced gastric cancer (AGC): The START trial.

Y. H. Kim, Wasaburo Koizumi, Kyung‐Hoon Lee et al. · Journal of Clinical Oncology · 2011 · 29 citations

Advanced Gastric Cancer, Cancer Management, Gastroenterology +21

Reinforcement of molten carbonate fuel cell matrixes by adding rod-shaped γ-LiAlO2 particles

Sang-Hoon Hyun, S. C. Cho, Jungwon Cho et al. · Journal of Materials Science · 2001 · 23 citations